Concepedia

Louis Storace

LS

Statistics

Publications

7

Citations

259

H-Index

7

Active since

1980

Affiliations

DuPont (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (United States)

Louis Storace is an author at DuPont (United States) specializing in medicinal chemistry, synthetic medicinal chemistry, and chemistry.

Publications per year

1980–2005

7

Publications

7

Stereoselective Synthesis of HIV-1 Protease Inhibitor, DMP 323

Michael E. Pierce, Gregory D. Harris, Qamrul Islam et al. · The Journal of Organic Chemistry · 1996 · 60 citations

, , +9

General Scope of 1,4-Diastereoselective Additions to a 2(3<i>H</i>)-Quinazolinone:  Practical Preparation of HIV Therapeutics

Nicholas A. Magnus, Pat N. Confalone, Louis Storace et al. · The Journal of Organic Chemistry · 2002 · 54 citations

, , +17

An Efficient Large-Scale Process for the Human Leukocyte Elastase Inhibitor, DMP 777<sup>1</sup>

Louis Storace, Luigi Anzalone, Pat N. Confalone et al. · Organic Process Research & Development · 2001 · 51 citations

, , +7

A new asymmetric 1,4-addition method: application to the synthesis of the HIV non-nucleoside reverse transcriptase inhibitor DPC 961

Nicholas A. Magnus, Pat N. Confalone, Louis Storace · Tetrahedron Letters · 2000 · 46 citations

, , +7

The chiral specific synthesis of DMP 754, a platelet GP antagonist

Linhua Zhang, Luigi Anzalone, Phillip Ma et al. · Tetrahedron Letters · 1996 · 21 citations

, , +15

1–5 of 7